Health in Latvia 1,264 indicators covering health for Latvia. IndicatorLatest Year10-yr change Rank Proportion of bloodstream infection due to Escherichia coli resistant 22.9% 2023 down 18.8% 37th Reported cases of gonorrhea 134 2023 down 75.8% 28th Reported cases of syphilis 15 2023 down 88.2% 34th Causes of death - potential years of life lost by treatable and 7,158 2023 down 16.3% 1st Treatable and preventable mortality of residents by cause and sex 9,053 2023 down 15.6% 24th Antimicrobial resistance or decreased susceptibiity (DS/R) to 14.29 2019 — 22nd Antimicrobial resistance or decreased susceptibiity (DS/R) to 7 2019 down 22.2% 46th Proportion of bloodstream infection due to methicillin-resistant 3.0% 2023 up 49.5% 51st Causes of death - infant mortality by country of residence 37 2023 down 59.8% 27th Influenza vaccination rate elderly oecd 9.1 2020 up 658.3% 33rd Reported cases of chlamydia 1,108 2023 down 45.9% 19th Excess mortality by month -15 2026 down 150.3% 30th Breast cancer screening coverage in europe 30.2 2022 down 7.6% 21st Consumption of antibiotics in the community and hospital sectors 15.4 2024 up 18.5% 21st Total use of antibacterials expressed as DDD per 1000 inhabitants per 15.05 2023 up 10.3% 33rd Pattern of antibiotic consumption at national level 71.99 2023 up 3.1% 15th Number of people spending more than 10% of household consumption or 242,000.0% 2006 — 28th Number of people spending more than 25% of household consumption or 41,000.0% 2006 — 25th Number of people pushed below the $2.15 ($ 2017 PPP) poverty line by o 1,000 2006 — 17th Number of people pushed below the $3.65 ($ 2017 PPP) poverty line by o 2,000 2006 — 26th Cancer screening rates in europe 46.7 2022 up 74.9% 13th Cervical cancer screening coverage in europe 46.7 2022 up 74.9% 13th Infant mortality by mother's educational attainment level (ISCED11f) 19 2024 — 29th Imports in 1000s hectolitres 303 2007 up 116.4% 22nd Population with household spending on health greater than 25% of 4.4% 2016 up 208.5% 6th Population pushed below a relative poverty line by household health 4.2% 2016 up 100.0% 4th Increase in poverty gap due to household health expenditures 1.2% 2016 up 74.3% 5th Number of isolates tested for ceftriaxone 7 2019 down 22.2% 50th Proportion of isolates with decreased susceptibility or resistance 0 2019 — 13th Population pushed below the $3.20 a day poverty line by household 0.0% 2016 down 100.0% 35th Increase in poverty gap due to household health expenditures 0.0% 2016 down 100.0% 35th Increase in poverty gap due to household health expenditures 0.0% 2016 down 100.0% 35th Population pushed below the $1.90 a day poverty line by household 0.0% 2016 down 100.0% 28th Increase in poverty gap due to household health expenditures 0.0% 2016 — 26th Population pushed below the $2.15 a day poverty line by household 0.0% 2016 down 100.0% 26th Increase in poverty gap due to household health expenditures 0.0% 2016 — 25th Population pushed further below the $3.20 a day poverty line by 0.0% 2016 down 100.0% 37th Population pushed below the $3.65 a day poverty line by household 0.0% 2016 down 100.0% 34th Population pushed further below the $3.65 a day poverty line by 0.0% 2016 down 100.0% 36th Proportion of isolates with resistance to azithromycin reported to 14.3 2019 — 11th Number of isolates tested for azithromycin 7 2019 down 22.2% 45th Households with out-of-pocket payments greater than 40% of capacity 15.0% 2016 up 60.0% 5th Proportion of isolates with resistance to ciprofloxacin reported to 60 2018 up 440.0% 26th Number of isolates tested for ciprofloxacin 5 2018 down 44.4% 53rd 4.1.1 Proportion of children and young people at the end of lower 82.68 2018 up 6.8% 13th Proportion of isolates with decreased susceptibility or resistance 0 2018 — 25th Number of isolates tested for extended-spectrum cephalosporins 5 2018 down 44.4% 49th 4.1.1 Proportion of children and young people at the end of lower 77.56 2018 down 5.9% 24th Proportion of children at the end of lower secondary achieving at 78.6% 2015 down 0.9% 22nd Exports of beer (barley) in 1000s hectolitres 125 2009 up 635.3% 29th Proportion of isolates with decreased susceptibility or resistance 0 2018 — 15th Number of isolates tested for cefixime 5 2018 down 44.4% 26th Availability of estimates on large health expenditures as a share of 1 2006 — 1st Availability of estimates on impoverishment due to out-of-pocket 1 2006 — 1st Civil registration coverage of cause-of-death 99.9% 2012 up 1.0% 25th Alcohol-related road traffic crashes with fatalities 14.5% 2012 down 49.3% 14th Alcohol-related road traffic crashes with fatalities 14.5% 2012 down 49.3% 14th Sales of wine in 1000s hectolitres 104 2007 down 29.3% 26th Alcohol-related road traffic crashes with fatalities, per 100,000 1.1 2010 down 82.8% 11th Alcohol-related road traffic crashes with fatalities, per 100,000 1.1 2010 down 82.8% 11th ← Previous Page 21 of 22 Next →